NDC 68135-020 – Naglazyme

Galsulfase 5 mg/5mL · Solution · Intravenous

Human Prescription Drug

Product NDC68135-020

Product details

Brand name
Naglazyme
Generic name
galsulfase
Labeler
BioMarin Pharmaceutical Inc.
Dosage form
Solution
Route
Intravenous
Marketing category
BLA · BLA125117
Marketed since
June 9, 2005
Listing expires
December 31, 2026
Pharmacologic class
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme

Active ingredients

Uses, dosage, side effects and warnings for Naglazyme →

Package NDC codes (1)

Package NDCDescriptionSince
68135-020-011 VIAL in 1 CARTON (68135-020-01) / 5 mL in 1 VIALJun 9, 2005